FierceBiotech 26 may 2026 Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues
FierceBiotech 26 may 2026 Facing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs
Eli Lilly 26 may 2026 Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues - Fierce Biotech
Eli Lilly 26 may 2026 Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company - investor.lilly.com